Research Library
Regulatory and Responsible Research·Discovery & Development·6 min read

Peptide Manufacturing: From Solid-Phase Synthesis to Purification

Peptide manufacturing is a sequence of chemical reactions and separations. Every stage can create impurities that must be understood and controlled.

By
Jacob Doyon, Researcher, Cendrix
Reviewed by
Jacob Leisher, Researcher, Cendrix
Published
April 26, 2026
Last reviewed
June 26, 2026

The final vial reflects the entire manufacturing history: raw materials, coupling efficiency, deprotection, cleavage, purification, drying, and storage.

Solid-phase peptide synthesis builds the chain stepwise

In solid-phase peptide synthesis, the first amino acid is attached to a resin. Protected amino acids are added one at a time through cycles of deprotection, activation, coupling, and washing. The growing chain remains attached to the solid support until synthesis is complete. Incomplete coupling or deprotection can create deletion sequences, truncated products, or chemically modified residues. Longer sequences generally increase the opportunity for cumulative error.

Protecting groups control reactivity

Temporary and side-chain protecting groups prevent unwanted reactions during assembly. Their selection must balance stability during synthesis with complete removal during cleavage. Residual protecting groups or side reactions can create impurities that are difficult to separate.

Cleavage releases the crude peptide

After assembly, cleavage reagents detach the peptide from the resin and remove many protecting groups. This step can also cause oxidation, alkylation, rearrangement, or damage to sensitive residues. Scavengers and carefully controlled conditions reduce side reactions.

Purification separates related species

Crude peptide can contain full-length product, deletion sequences, truncated peptides, stereochemical impurities, oxidized forms, adducts, and reagent residues. Preparative chromatography is commonly used to enrich the intended product. Closely related impurities may co-elute and require optimized methods.

Isolation and lyophilization affect the final material

Purified fractions are concentrated, exchanged into a selected counterion or buffer, and dried. Lyophilization can produce a stable cake, but residual water, counterions, and handling conditions affect measured mass and stability.

Scale changes the process

A process developed at milligram scale may behave differently at gram or kilogram scale. Mixing, heat transfer, reagent consumption, purification loading, solvent use, and drying become major engineering variables.

This article is provided for scientific and educational purposes. It does not describe or recommend human or veterinary use. Research findings may be limited by study design, model selection, material identity, sample size, or lack of independent replication.

Cendrix analysis

manufacturing path is part of a peptide's quality profile. A clean chromatogram at the end does not eliminate the need to understand identity, process-related impurities, content, counterions, and stability.

Selected primary references

  1. [1]Peptide manufacturing and green chemistry review
  2. [2]FDA guidance on synthetic peptide impurities
  3. [3]Therapeutic peptides: current applications and future directions

Editorial note. Written by Jacob Doyon and scientifically reviewed by Jacob Leisher. See our editorial standards, citation policy, and corrections policy.